Related Experiment Video
Updated: Jul 20, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Medical therapy: where are we now?
1Department of Pharmacy, Clinical and Administrative Sciences, The University of Oklahoma College of Pharmacy, P.O. Box 26901, Oklahoma City, OK 73190, USA. Beth-Resman-Targoff@ouhsc.edu
Summary
Early treatment with traditional disease-modifying antirheumatic drugs (DMARDs) is crucial for rheumatoid arthritis (RA). Optimal use of these medications, alongside biologics, significantly improves long-term outcomes and reduces joint damage.
Area of Science:
- Rheumatology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory condition requiring effective disease management.
- Traditional disease-modifying antirheumatic drugs (DMARDs) form a cornerstone of RA therapy.
Purpose of the Study:
- To review the mechanisms of action, safety, and efficacy of nonbiologic DMARDs: methotrexate, sulfasalazine, leflunomide, and hydroxychloroquine.
- To discuss critical aspects of rheumatoid arthritis clinical trial interpretation, including response criteria, outcome measures, study designs, and combination therapy results.
Main Methods:
- Literature review of nonbiologic DMARDs.
- Analysis of rheumatoid arthritis clinical trial methodologies and findings.
Main Results:
- Nonbiologic DMARDs suppress inflammation, reduce pain and stiffness, and can slow RA disease progression.
- Optimal use of DMARDs, combined with an understanding of clinical trial data, has driven significant treatment progress.
Conclusions:
- Early and aggressive inflammation suppression in RA leads to long-term benefits and improved prognosis.
- The judicious use of DMARDs and biologic agents is key to altering the course of RA and minimizing joint damage.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Psychotherapy
Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.